resveratrol has been researched along with exudates in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Freyer, AJ; Killmer, LB; Porter, JR; Zgoda-Pols, JR | 1 |
Abe, N; Iinuma, M; Ito, M; Ito, T; Masuda, Y; Nasu, M; Nozawa, Y; Ohguchi, K; Oyama, M | 1 |
Alós, J; Arjumand, J; Härtel, D; Hohl, C; Korosoglou, G; Langhoff, R; Martínez, E; Raut, W; Reimer, P; Riazi, H; Romani, S; Schmidt, A; Waliszewski, M; Yahya, SA | 1 |
3 other study(ies) available for resveratrol and exudates
Article | Year |
---|---|
Antimicrobial resveratrol tetramers from the stem bark of Vatica oblongifoliassp. oblongifolia.
Topics: Ericales; Malaysia; Methicillin Resistance; Molecular Conformation; Molecular Structure; Mycobacterium smegmatis; Nuclear Magnetic Resonance, Biomolecular; Plant Stems; Plants, Medicinal; Resveratrol; Staphylococcus aureus; Stilbenes | 2002 |
Resveratrol oligomers from Vatica albiramis.
Topics: Dipterocarpaceae; Fibroblasts; Humans; Interleukin-1beta; Malaysia; Matrix Metalloproteinase 1; Molecular Structure; Phenols; Plant Stems; Plants, Medicinal; Resveratrol; Skin; Stereoisomerism; Stilbenes | 2010 |
The Real-World CONSEQUENT ALL COMERS Study: Predictors for Target Lesion Revascularization and Mortality in an Unselected Patient Population.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Cardiovascular Agents; Cause of Death; Coated Materials, Biocompatible; Europe; Female; Femoral Artery; Humans; Malaysia; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Recurrence; Resveratrol; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Vascular Access Devices; Vascular Patency | 2021 |